Safety and Feasibility of Cultivated Autologous Limbal Stem Cells (cLSC) for Limbal Stem Cell Deficiency

Investigator(s):
Organization: 
UCLA
NCT Number: 
Disease Name: 
Limbal Stem-cell Deficiency
Disease Category: 
Trial Phases: 
Phase 1
Trial Status: 
Recruiting
Sophie Deng, M.D., Ph.D.
Sophie Deng, M.D., Ph.D.
Trial Contact: 

Sheyla Gonzalez
(310) 825-6232
s.gonzalez@jsei.ucla.edu